Cargando…
A study to assess the outcome in COVID-19 confirmed cases receiving Remdesivir as compared to conventional therapy: Medical records-based audit
INTRODUCTION: COVID-19 infection caused by SARS-Corona virus-2 (SARS-CoV-2) has caused large number of infections and mortality globally. There are no proven medications to prevent and treat COVID-19, nevertheless several potential pharmacotherapeutic agents have been tried. Remdesivir was found to...
Autores principales: | Prabhu, Divya, Kulkarni, Ashwin, Thyagaraj, Vijayashree, Balaji, Vijay, Kumar, Thimmaiah Anil, Rao, Medha Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480757/ https://www.ncbi.nlm.nih.gov/pubmed/36119268 http://dx.doi.org/10.4103/jfmpc.jfmpc_1780_21 |
Ejemplares similares
-
A Prospective, Randomized, Single-Blind, Comparative Study of Dexmedetomidine and Propofol Infusion for Intraoperative Hemodynamics and Recovery Characteristics in Laparoscopic Surgeries
por: Janardhana, Vasantha Kumar, et al.
Publicado: (2019) -
Clinical and Laboratory Profile of Patients Visiting the Post-COVID-19 Clinic at a Tertiary Care Hospital: A Cross-Sectional Study
por: Thyagaraj, Vijayashree, et al.
Publicado: (2022) -
When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022) -
Significance of serum procalcitonin in sepsis
por: Sudhir, Uchil, et al.
Publicado: (2011) -
Endobronchial Tuberculosis: Two Case Reports and Review of the Literature
por: Aneja, Anshum, et al.
Publicado: (2014)